CME Presentations

Heart Failure


Presentations


Speakers


CME Information

Heart Failure – From Prognostic Modeling to Therapy in Patient with HFrEF


PIM LogoPQH Logo

LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

  • Incorporate the recent updates from the 2017 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure into clinical practice
  • Recognize the multiple barriers that hinder the application of guideline-directed medical therapy in patients with HF
  • Provide optimal therapeutic dosing of recently introduced options to enhance health outcomes in patients with HF
  • Identify risk factors for significant morbidity and mortality that are associated with HF, particularly post hospitalization

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Novartis.

TUITION

Complimentary

Jointly Accredited Provider Logo





JOINT ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

Live Activity
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION

Live Internet Activity
September 20, 2019 from 11:00 AM EDT – 1:00 PM EDT.

Enduring Material
The enduring material will be available from September 20, 2019 to March 20, 2020.

TARGET AUDIENCE

This activity is intended for cardiologists, interventional cardiologists, primary care physicians, internists, advanced practitioners (nurse practitioners, physician assistants), pharmacists, and other health care providers who care for patients with heart failure.

ESTIMATED TIME TO COMPLETE

This activity consists of two sessions which should take approximately 2 hours to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To participate in the activity, go to www.CardioCareLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.

HARDWARE / SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

DISCLOSURE OF CONFLICTS OF INTEREST

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
James L. Januzzi, Jr., MD, FACC, FESC
Physician, Cardiology Division
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Massachusetts General Hospital
Hutter Family Professor of Medicine in the Field of Cardiology
Harvard Medical School
Cardiometabolic Faculty
Baim Institute for Clinical Research
TBD
Gregg C. Fonarow, MD, FACC, FAHA, FHFSA
Eliot Corday Professor of Cardiovascular Medicine and Science
Director, Ahmanson-UCLA Cardiomyopathy Center
Co-Chief, UCLA Division of Cardiology
Co-Director, UCLA Preventative Cardiology Program
David Geffen School of Medicine at UCLA
TBD
Nasrien E. Ibrahim, MD
Assistant Professor of Medicine
Harvard Medical School
Associate Director, Resynchronization & Advanced Cardiac Therapeutics Program
Massachusetts General Hospital
TBD

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner Reported Financial Relationship
Joe Chebli Medical Director PlatformQ Health Education, LLC None

The PIM planners and managers have nothing to disclose.

The following PlatformQ Health Education, LLC planner, Alissa Yost, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
Please contact the Postgraduate Institute for Medicine at www.pimed.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact CardioCareLive at 877-394-1306 or at Support@CardioCareLive.com.